This Google™ translation feature is provided for informational purposes only. The Office of the Attorney General is unable to guarantee the accuracy of this translation and is therefore not liable for any inaccurate information resulting from the translation application tool. Please consult with a translator for accuracy if you are relying on the translation or are using this site for official business. Hisense Usb Driver. Samsung Bada Apps Whatsapp For Windows.

If you have any questions please contact: Bilingual Services Program at (916) 324-5482 A copy of this disclaimer can also be found on our page. Select a Language Below / Seleccione el Idioma Abajo. CURES Mandate To assist health care practitioners in their efforts to ensure appropriate prescribing, ordering, administering, furnishing, and dispensing of controlled substances, law enforcement and regulatory agencies in their efforts to control the diversion and resultant abuse of Schedule II, Schedule III, and Schedule IV controlled substances, and for statistical analysis, education, and research, the Department of Justice shall... Maintain the Controlled Substance Utilization Review and Evaluation System (CURES) Health and Safety Code section § 11165.

(a) Controlled Substance Utilization Review and Evaluation System California’s Prescription Drug Monitoring Program CURES 2.0 (Controlled Substance Utilization Review and Evaluation System) is a database of Schedule II, III and IV controlled substance prescriptions dispensed in California serving the public health, regulatory oversight agencies, and law enforcement. CURES 2.0 is committed to the reduction of prescription drug abuse and diversion without affecting legitimate medical practice or patient care. The Health Insurance Portability and Accountability Act of 1996 (HIPAA) and confidentiality and disclosure provisions of California law cover the information contained in CURES 2.0. Access to CURES 2.0 is limited to licensed prescribers and licensed pharmacists strictly for patients in their direct care; and regulatory board staff and law enforcement personnel for official oversight or investigatory purposes.